img

Global and United States PD-L1 Biomarker Testing Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States PD-L1 Biomarker Testing Market Report & Forecast 2024-2034

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
Market Analysis and InsightsGlobal and United States PD-L1 Biomarker Testing Market
This report focuses on global and United States PD-L1 Biomarker Testing market, also covers the segmentation data of other regions in regional level and county level.
The global PD-L1 Biomarker Testing revenue was US$ 1470.5 million in 2022 and is forecast to a readjusted size of US$ 14870 million by 2033 with a CAGR of 38.7% during the review period (2023-2033).
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
Global PD-L1 Biomarker Testing Scope and Market Size
PD-L1 Biomarker Testing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global PD-L1 Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the PD-L1 Biomarker Testing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Agilent Technologies
Roche
Segment by Type
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other

Segment by Application


Hospital
Diagnostic Center
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces PD-L1 Biomarker Testing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of PD-L1 Biomarker Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of PD-L1 Biomarker Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-L1 Biomarker Testing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 PD-L1 Biomarker Testing Product Introduction
1.2 Global PD-L1 Biomarker Testing Outlook 2018 VS 2022 VS 2033
1.2.1 Global PD-L1 Biomarker Testing Market Size for the Year 2018-2033
1.2.2 United States PD-L1 Biomarker Testing Market Size for the Year 2018-2033
1.3 PD-L1 Biomarker Testing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States PD-L1 Biomarker Testing in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of PD-L1 Biomarker Testing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 PD-L1 Biomarker Testing Market Dynamics
1.4.1 PD-L1 Biomarker Testing Industry Trends
1.4.2 PD-L1 Biomarker Testing Market Drivers
1.4.3 PD-L1 Biomarker Testing Market Challenges
1.4.4 PD-L1 Biomarker Testing Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 PD-L1 Biomarker Testing by Type
2.1 PD-L1 Biomarker Testing Market Segment by Type
2.1.1 PD-L1 (22C3)
2.1.2 PD-L1(28-8)
2.1.3 PD-L1 (SP142)
2.1.4 PD-L1 (SP263)
2.1.5 Other
2.2 Global PD-L1 Biomarker Testing Market Size by Type (2018, 2022 & 2033)
2.3 Global PD-L1 Biomarker Testing Market Size by Type (2018-2033)
2.4 United States PD-L1 Biomarker Testing Market Size by Type (2018, 2022 & 2033)
2.5 United States PD-L1 Biomarker Testing Market Size by Type (2018-2033)
3 PD-L1 Biomarker Testing by Application
3.1 PD-L1 Biomarker Testing Market Segment by Application
3.1.1 Hospital
3.1.2 Diagnostic Center
3.1.3 Others
3.2 Global PD-L1 Biomarker Testing Market Size by Application (2018, 2022 & 2033)
3.3 Global PD-L1 Biomarker Testing Market Size by Application (2018-2033)
3.4 United States PD-L1 Biomarker Testing Market Size by Application (2018, 2022 & 2033)
3.5 United States PD-L1 Biomarker Testing Market Size by Application (2018-2033)
4 Global PD-L1 Biomarker Testing Competitor Landscape by Company
4.1 Global PD-L1 Biomarker Testing Market Size by Company
4.1.1 Global Key Companies of PD-L1 Biomarker Testing, Ranked by Revenue (2022)
4.1.2 Global PD-L1 Biomarker Testing Revenue by Player (2018-2023)
4.2 Global PD-L1 Biomarker Testing Concentration Ratio (CR)
4.2.1 PD-L1 Biomarker Testing Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of PD-L1 Biomarker Testing in 2022
4.2.3 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of PD-L1 Biomarker Testing Head office and Area Served
4.4 Global Key Players of PD-L1 Biomarker Testing, Product and Application
4.5 Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States PD-L1 Biomarker Testing Market Size by Company
4.7.1 Key Players of PD-L1 Biomarker Testing in United States, Ranked by Revenue (2022)
4.7.2 United States PD-L1 Biomarker Testing Revenue by Players (2021, 2022 & 2023)
5 Global PD-L1 Biomarker Testing Market Size by Region
5.1 Global PD-L1 Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global PD-L1 Biomarker Testing Market Size by Region (2018-2033)
5.2.1 Global PD-L1 Biomarker Testing Market Size by Region: 2018-2023
5.2.2 Global PD-L1 Biomarker Testing Market Size by Region (2024-2033)
6 Americas
6.1 Americas PD-L1 Biomarker Testing Market Size YoY Growth 2018-2033
6.2 Americas PD-L1 Biomarker Testing Market Size by Type
6.2.1 Americas PD-L1 Biomarker Testing Market Size by Type (2018-2023)
6.2.2 Americas PD-L1 Biomarker Testing Market Size by Type (2024-2033)
6.2.3 Americas PD-L1 Biomarker Testing Market Share by Type (2018-2033)
6.3 Americas PD-L1 Biomarker Testing Market Size by Application
6.3.1 Americas PD-L1 Biomarker Testing Market Size by Application (2018-2023)
6.3.2 Americas PD-L1 Biomarker Testing Market Size by Application (2024-2033)
6.3.3 Americas PD-L1 Biomarker Testing Market Share by Application (2018-2033)
6.4 Americas PD-L1 Biomarker Testing Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA PD-L1 Biomarker Testing Market Size YoY Growth 2018-2033
7.2 EMEA PD-L1 Biomarker Testing Market Size by Type
7.2.1 EMEA PD-L1 Biomarker Testing Market Size by Type (2018-2023)
7.2.2 EMEA PD-L1 Biomarker Testing Market Size by Type (2024-2033)
7.2.3 EMEA PD-L1 Biomarker Testing Market Share by Type (2018-2033)
7.3 EMEA PD-L1 Biomarker Testing Market Size by Application
7.3.1 EMEA PD-L1 Biomarker Testing Market Size by Application (2018-2023)
7.3.2 EMEA PD-L1 Biomarker Testing Market Size by Application (2024-2033)
7.3.3 EMEA PD-L1 Biomarker Testing Market Share by Application (2018-2033)
7.4 EMEA PD-L1 Biomarker Testing Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China PD-L1 Biomarker Testing Market Size YoY Growth 2018-2033
8.2 China PD-L1 Biomarker Testing Market Size by Type
8.2.1 China PD-L1 Biomarker Testing Market Size by Type (2018-2023)
8.2.2 China PD-L1 Biomarker Testing Market Size by Type (2024-2033)
8.2.3 China PD-L1 Biomarker Testing Market Share by Type (2018-2033)
8.3 China PD-L1 Biomarker Testing Market Size by Application
8.3.1 China PD-L1 Biomarker Testing Market Size by Application (2018-2023)
8.3.2 China PD-L1 Biomarker Testing Market Size by Application (2024-2033)
8.3.3 China PD-L1 Biomarker Testing Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC PD-L1 Biomarker Testing Market Size YoY Growth 2018-2033
9.2 APAC PD-L1 Biomarker Testing Market Size by Type
9.2.1 APAC PD-L1 Biomarker Testing Market Size by Type (2018-2023)
9.2.2 APAC PD-L1 Biomarker Testing Market Size by Type (2024-2033)
9.2.3 APAC PD-L1 Biomarker Testing Market Share by Type (2018-2033)
9.3 APAC PD-L1 Biomarker Testing Market Size by Application
9.3.1 APAC PD-L1 Biomarker Testing Market Size by Application (2018-2023)
9.3.2 APAC PD-L1 Biomarker Testing Market Size by Application (2024-2033)
9.3.3 APAC PD-L1 Biomarker Testing Market Share by Application (2018-2033)
9.4 APAC PD-L1 Biomarker Testing Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Agilent Technologies
10.1.1 Agilent Technologies Company Details
10.1.2 Agilent Technologies Business Overview
10.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
10.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2018-2023)
10.1.5 Agilent Technologies Recent Development
10.2 Roche
10.2.1 Roche Company Details
10.2.2 Roche Business Overview
10.2.3 Roche PD-L1 Biomarker Testing Introduction
10.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2018-2023)
10.2.5 Roche Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. PD-L1 Biomarker Testing Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. PD-L1 Biomarker Testing Market Trends
Table 3. PD-L1 Biomarker Testing Market Drivers
Table 4. PD-L1 Biomarker Testing Market Challenges
Table 5. PD-L1 Biomarker Testing Market Restraints
Table 6. Global PD-L1 Biomarker Testing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States PD-L1 Biomarker Testing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global PD-L1 Biomarker Testing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States PD-L1 Biomarker Testing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of PD-L1 Biomarker Testing, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global PD-L1 Biomarker Testing Revenue by Player, (US$ Million), 2018-2023
Table 12. Global PD-L1 Biomarker Testing Revenue Share by Player, 2018-2023
Table 13. Global PD-L1 Biomarker Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2022)
Table 15. Global Key Players of PD-L1 Biomarker Testing, Headquarters and Area Served
Table 16. Global Key Players of PD-L1 Biomarker Testing, Product and Application
Table 17. Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of PD-L1 Biomarker Testing in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States PD-L1 Biomarker Testing Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States PD-L1 Biomarker Testing Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global PD-L1 Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas PD-L1 Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas PD-L1 Biomarker Testing Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas PD-L1 Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas PD-L1 Biomarker Testing Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA PD-L1 Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA PD-L1 Biomarker Testing Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA PD-L1 Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA PD-L1 Biomarker Testing Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA PD-L1 Biomarker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA PD-L1 Biomarker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. China PD-L1 Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 40. China PD-L1 Biomarker Testing Market Size by Type (2024-2033) & (US$ Million)
Table 41. China PD-L1 Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 42. China PD-L1 Biomarker Testing Market Size by Application (2024-2033) & (US$ Million)
Table 43. China PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC PD-L1 Biomarker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC PD-L1 Biomarker Testing Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC PD-L1 Biomarker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC PD-L1 Biomarker Testing Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC PD-L1 Biomarker Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC PD-L1 Biomarker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC PD-L1 Biomarker Testing Market Size by Region (2024-2033) & (US$ Million)
Table 51. Agilent Technologies Company Details
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies PD-L1 Biomarker Testing Product
Table 54. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2018-2023) & (US$ Million)
Table 55. Agilent Technologies Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche PD-L1 Biomarker Testing Product
Table 59. Roche Revenue in PD-L1 Biomarker Testing Business (2018-2023) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-L1 Biomarker Testing Product Picture
Figure 2. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global PD-L1 Biomarker Testing Market Size 2018-2033 (US$ Million)
Figure 4. United States PD-L1 Biomarker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States PD-L1 Biomarker Testing Market Size 2018-2033 (US$ Million)
Figure 6. United States PD-L1 Biomarker Testing Market Share in Global 2018-2033
Figure 7. PD-L1 Biomarker Testing Report Years Considered
Figure 8. Product Picture of PD-L1 (22C3)
Figure 9. Product Picture of PD-L1(28-8)
Figure 10. Product Picture of PD-L1 (SP142)
Figure 11. Product Picture of PD-L1 (SP263)
Figure 12. Product Picture of Other
Figure 13. Global PD-L1 Biomarker Testing Market Share by Type in 2022 & 2033
Figure 14. Global PD-L1 Biomarker Testing Market Size by Type (2018-2033) & (US$ Million)
Figure 15. Global PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 16. United States PD-L1 Biomarker Testing Market Share by Type in 2022 & 2033
Figure 17. United States PD-L1 Biomarker Testing Market Size by Type (2018-2033) & (US$ Million)
Figure 18. United States PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Diagnostic Center
Figure 21. Product Picture of Others
Figure 22. Global PD-L1 Biomarker Testing Market Share by Application in 2022 & 2033
Figure 23. Global PD-L1 Biomarker Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 24. Global PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 25. United States PD-L1 Biomarker Testing Market Share by Application in 2022 & 2033
Figure 26. United States PD-L1 Biomarker Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 27. United States PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 28. The Top 5 and 10 Largest Companies of PD-L1 Biomarker Testing in the World: Market Share by PD-L1 Biomarker Testing Revenue in 2022
Figure 29. Global PD-L1 Biomarker Testing Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 30. Global PD-L1 Biomarker Testing Market Share by Region (2018-2033)
Figure 31. Americas PD-L1 Biomarker Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 32. Americas PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 33. Americas PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 34. United States PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Canada PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Mexico PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. Brazil PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 38. EMEA PD-L1 Biomarker Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 39. EMEA PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 40. EMEA PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 41. Europe PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Middle East PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. Africa PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 44. China PD-L1 Biomarker Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. China PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 46. China PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 47. APAC PD-L1 Biomarker Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 48. APAC PD-L1 Biomarker Testing Market Share by Type (2018-2033)
Figure 49. APAC PD-L1 Biomarker Testing Market Share by Application (2018-2033)
Figure 50. Japan PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. South Korea PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. China Taiwan PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Southeast Asia PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. India PD-L1 Biomarker Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 55. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed